Fig. 1From: DNA methylation subtypes guiding prognostic assessment and linking to responses the DNA methyltransferase inhibitor SGI-110 in urothelial carcinomaFlow diagram of the study. A training cohort of 45 UC samples and two validation cohorts were used for classification and prognosis analysis. RNA-seq data of 9 UTUC patients revealed the transcriptional features of the two subtypes. WGBS and RNA-seq were performed on SGI-110-treated cell linesBack to article page